SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community rallies around its potential, emphasizing its resilience as a long-term project in the crypto space. Token burns are a hot topic, with the community eagerly anticipating one at 2500 watchers. Discussions highlight the active community and ongoing development efforts, reinforcing a commitment to shaking up the market.

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. The firm is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.

Crinetics Pharmaceuticals Inc

CRNX is trending due to bullish sentiment after positive analyst coverage and discussion around potential short squeezes; the community is actively debating the stock's valuation and future price movement, particularly in light of its recent FDA approval for PALSONIFY. Some traders are expressing concerns about the stock being overvalued, while others are optimistic about its long-term potential and pipeline.

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending as the crypto market experiences volatility, leading to liquidations and discussions about potential support levels. Community members are debating whether this is a temporary dip or the start of a larger correction, while also considering upcoming options expirations and potential impacts from macroeconomic factors. Some traders are anticipating a strong October, while others remain cautious.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group (DJT) is trending amid heated discussions surrounding potential tariffs and their impact on various sectors. The community is split, with some users expressing concerns about economic consequences and potential political motivations, while others defend the actions as necessary for protecting domestic industries. Broader debates encompass political ideologies and the role of government intervention in the economy.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), Global Services (BGS), and Boeing Capital (BCC). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The Boeing Capital segment seeks to ensure that Boeing customers have the financing they need to buy and take delivery of their Boeing product and manages overall financing exposure. The company was founded by William Edward Boeing on July 15, 1916 and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is trending due to easing FAA restrictions and securing new orders, including a significant deal with Turkish Airlines. The community is debating whether these positive catalysts will translate to a meaningful production ramp-up and stock price movement, especially with ongoing labor negotiations. Some investors express concerns about Boeing's ability to execute its backlog and improve quality, while others see it as a long-term buy opportunity.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology's stock is trending due to a recently filed 6-K related to a $1.4 billion contract, sparking bullish sentiment and discussions about the company's cash flow. The community is debating the significance of the contract details and whether additional capital will be needed. Some investors express concerns about Robinhood's actions and institutional short positions affecting the stock's performance.

Pupu is a community-driven meme project centered around the character “Pupu the Frog,” who represents lighthearted fun and adventure within the crypto space. The project aims to build a digital ecosystem where holders can engage with the narrative of Pupu through memes, social interactions, and community activities. At its core, the project highlights creativity, entertainment, and community participation as primary utilities, while maintaining a transparent and decentralized structure that evolves through user engagement.

Pupu

$PUPU.X is trending as community members highlight its potential as the next PEPE, with many pointing to its availability on Phantom Wallet as a catalyst. The conversation also mentions the token's chart patterns and strong buying activity. Some users are monitoring whale activity and discussing ease of use through Phantom.

Riot Platforms, Inc. is a bitcoin mining company, which engages in the provision of special cryptocurrency mining computers. It invests in Verady, Coinsquare, and Tess. It operates through the Bitcoin Mining and Engineering segments. The Bitcoin Mining segment focuses on maximizing ability to successfully mine Bitcoin by growing hash rate. The Engineering segment designs and manufactures power distribution equipment and custom engineered electrical products that provides them the ability to vertically integrate many of the critical electrical components and engineering service. The company was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Riot Platforms Inc

Riot Blockchain Inc

Riot Platforms ($RIOT) is trending as investors discuss recent upgrades from analysts at J.P. Morgan and Roth Capital, driving pre-market interest and speculation of a continued run. Community chatter revolves around target price hikes and potential catalysts, including the company's AI and high-performance computing (HPC) diversification plans.  Amidst broader discussions about Bitcoin miners and their correlation with crypto prices, some traders are weighing Riot's potential for further gains against concerns of market corrections.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

Iris Energy Ltd

IREN is trending as investors react to analyst upgrades and debate the company's potential in the AI cloud infrastructure space, with some highlighting its strong momentum and others cautioning about overbought conditions. Community members are actively discussing price targets, potential deals with hyperscalers, and comparing IREN to other stocks in the sector. A JPMorgan downgrade and insiders selling off shares adds to the volatility, sparking debate about market manipulation.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

Federal National Mortgage Association ($FNMA) is trending amid discussions of its potential IPO and comments from Secretary Lutnick hinting at a sooner-than-expected public offering, which the community believes could be the largest IPO in history. Investors are also reacting to Deutsche Bank initiating coverage with a "buy" rating and a price target of $20. Community members are closely following insights from key figures like Pulte and Bessent, interpreting their statements for clues about the future of the GSEs and potential benefits for common shareholders.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Analysts Predict a 106.48% Upside in Enliven Therapeutics, Inc. (ELVN): Here's  What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 106.5% in Enliven Therapeutics, Inc. (ELVN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Enliven Therapeutics, Inc. (ELVN) Upgraded to Buy: Here's What You Should Know

Enliven Therapeutics, Inc. (ELVN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

How Much Upside is Left in Enliven Therapeutics, Inc. (ELVN)? Wall Street Analysts Think 102.41%

The consensus price target hints at a 102.4% upside potential for Enliven Therapeutics, Inc. (ELVN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Can Enliven Therapeutics, Inc. (ELVN) Climb 75.66% to Reach the Level Wall Street Analysts Expect?

The consensus price target hints at a 75.7% upside potential for Enliven Therapeutics, Inc. (ELVN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Short sellers pulled back from Enliven Therapeutics last week, with Ortex data, compiled by The Fly,&nbsp; showing a sharp decline in short interest from 25.7% to 18.4% — the lowest since April 2023.&nbsp;The unwind coincided with a spike in trading volume, triggered by updated Phase 1 results for the company’s chronic myeloid leukemia (CML) candidate ELVN-001 and a bullish initiation from Goldman Sachs.Enliven Therapeutics shares closed at $21.3 on Friday, down 1.3% on the day.Ortex also reported that days to cover, a key metric representing the average number of days it would take shorts to cover their positions at current volume, dropped to 6.9 from 7.8, a nine-month low.&nbsp;The estimated short interest had ranged between 24% and 29% since October 2023.The catalyst was the company’s presentation at the European Hematology Association (EHA) Congress in Milan.&nbsp;Updated data from the ongoing Phase 1 ENABLE trial showed that 25 of 53 evaluable patients without the T315I mutation,&nbsp;or nearly 47%, achieved or maintained major molecular response (MMR) by week 24.&nbsp;The patients in the study were heavily pretreated, with 67% having received three or more prior TKIs.Enliven said ELVN-001 remained well-tolerated across all doses.&nbsp;The drug showed no signs of enhanced cardiovascular risk or arterial occlusive events, with just 3.4% of patients requiring dose reductions due to adverse events and 4.6% discontinuing due to side effects.&nbsp;The drug’s pharmacokinetics support once-daily oral dosing without fasting restrictions and minimal drug-drug interaction, which is a key benefit given&nbsp;that the average CML patient takes about five medications.Additionally, Goldman Sachs initiated coverage on Enliven Therapeutics with a ‘Buy’ rating and a $37 price target, citing positive Phase 1 data for ELVN-001 and plans to start a Phase 3 trial in 2026.&nbsp;The firm said the drug remains well-tolerated, with no added cardiovascular risk, and highlighted its once-daily dosing potential and minimal drug interaction profile.On Stocktwits, retail sentiment was ‘neutral’ amid ‘high’ message volume.The stock has declined 10.9% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Enliven Short Interest Falls To 14-Month Low After Leukemia Trial Data, Goldman Initiates With ‘Buy’

Ortex data shows short interest in Enliven Therapeutics had hovered between 24% and 29% since October 2023.

Equity

Enliven Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

Enliven Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference Enliven Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference PR Newswire BOULDER, Colo., Feb...

Mizuho refreshes its US top picks list for January

Investing.com --  Mizuho  (NYSE:MFG) has updated its US Top Picks list for January, adding Chewy (NYSE:CHWY), GE Vernova (NYSE:GEV), Enliven Therapeutics Inc (NASDAQ:ELVN), Quest Diagnostics (NYSE:DGX), DuPont de Nemours (NYSE:DD), and Salesforce (NYSE:CRM). These selections reflect Mizuho’s highest-conviction ideas driven by catalysts expected to play out over the next 12 months.

Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update

Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update PR Newswire...

Enliven Therapeutics to Present at the Jefferies London Healthcare Conference

Enliven Therapeutics to Present at the Jefferies London Healthcare Conference Enliven Therapeutics to Present at the Jefferies London Healthcare Conference PR Newswire BOULDER, Colo., Nov. 7, 2024...

FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket

FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket PR Newswire VANCOUVER, BC, Oct. 4, 2024 USA News Group...

Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of small molecule therapeutics. Its pipeline includes BCR-ABL Program: ELVN-001and HER2 Program: ELVN-002. The company was founded by Samuel S. Kintz, Joseph P. Lyssikatos, and Anish Patel on June 1, 2019 and is headquartered in Boulder, CO.

Enliven Therapeutics Inc

$5,000

$6,000

$7,000

$8,000

What price will Ethereum hit in 2025? 
 
*Powered by Polymarket

ELVN
Enliven Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ELVN News

ELVN Enliven Therapeutics Inc